Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Work In Process: 2020-2025

Historic Work In Process for Burning Rock Biotech (BNR) over the last 4 years, with Sep 2025 value amounting to $1.8 million.

  • Burning Rock Biotech's Work In Process fell 27.52% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 27.52%. This contributed to the annual value of $10.4 million for FY2024, which is 9.68% down from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Work In Process is $1.8 million, which was down 89.33% from $17.2 million recorded in Q1 2025.
  • Burning Rock Biotech's 5-year Work In Process high stood at $58.8 million for Q2 2023, and its period low was $1.8 million during Q3 2025.
  • For the 3-year period, Burning Rock Biotech's Work In Process averaged around $21.5 million, with its median value being $10.9 million (2023).
  • As far as peak fluctuations go, Burning Rock Biotech's Work In Process surged by 783.48% in 2023, and later crashed by 95.66% in 2024.
  • Burning Rock Biotech's Work In Process (Quarterly) stood at $8.9 million in 2021, then increased by 25.95% to $11.2 million in 2022, then grew by 2.17% to $11.5 million in 2023, then decreased by 9.68% to $10.4 million in 2024, then dropped by 27.52% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $17.2 million for Q1 2025, and $10.4 million during Q4 2024.